Skip to main content

Military Health System

Utility Navigation Links

WEEKEND MAINTENANCE: The maintenance outage is scheduled for June 22nd at 6:00am EST ending NLT Sunday, June 23rd at 11:59pm Eastern EST. The TRICARE Manuals web site may be available intermittently during this period but it's usage is not recommended.

TRICARE Policy Manual 6010.63-M, April 2021
Chapter 4
Section 9.3
Intracoronary Stents
Issue Date:  July 8, 1998
Authority:  32 CFR 199.4(c)(2) and (c)(3)
Copyright:  CPT only © 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved.
92980, 92981
G0290, G0291
Intracoronary stenting consists of coils or tubes that are positioned within the coronary vessel to provide support or “scaffolding” to the internal vessel architecture. Most stents are metallic coils or tubes and balloon expandable or self-expanding.
4.1  Coronary artery stenting may be cost-shared for the following indications as an adjunct to percutaneous transluminal coronary angioplasty:
4.1.1  To reduce the incident of restenosis; and
4.1.2  For acute or threatened vessel closure following balloon angioplasty.
4.2  Coronary artery stents are covered for treatment of saphenous vein narrowing with previous coronary angioplasty bypass grafting.
4.3  Intracoronary stents must have United States (US) Food and Drug Administration (FDA) approval based on its specific intention.
5.1  November 1, 1996, for intracoronary stents.
5.2  April 24, 2003, for drug eluting stents.
- END -
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery